Skip to main content

Month: April 2025

Southern States Bancshares, Inc. Announces First Quarter 2025 Financial Results

First Quarter 2025 Performance and Operational HighlightsNet income of $10.4 million, or $1.03 per diluted share Core net income(1) of $10.3 million, or $1.03 per diluted share(1) Pretax pre-provision core net income(1) of $14.2 million Net interest income of $24.9 million, a decrease of $171,000 from the prior quarter Net interest margin (“NIM”) of 3.75%, up 9 basis points from the prior quarter Return on average assets (“ROAA”) of 1.48%; return on average stockholders’ equity (“ROAE”) of 14.67%; and return on average tangible common equity (“ROATCE”)(1) of 17.19% Core ROAA(1) of 1.47%; and core ROATCE(1) of 17.16% Efficiency ratio of 46.42% Linked-quarter loans grew 6.1% annualized Linked-quarter deposits grew 2.4% annualized(1) See “Reconciliation of Non-GAAP Financial Measures” below for reconciliation of non-GAAP financial...

Continue reading

IMUNON Announces IMNN-001 Abstract Accepted for Oral Presentation at 2025 ASCO Annual Meeting

Highly promising survival data from OVATION 2 Study of treatment of newly diagnosed advanced ovarian cancer to be presented  Initiation of Phase 3 trial sites underway for pivotal study of IMNN-001 following alignment on protocol with FDA LAWRENCEVILLE, N.J., April 21, 2025 (GLOBE NEWSWIRE) — IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that an abstract highlighting new, highly encouraging, Overall Survival data from the Phase 2 OVATION 2 Study of IMNN-001 to treat women with newly diagnosed advanced ovarian cancer was accepted for oral presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. The meeting is being held May 30 – June 3, 2025, in Chicago, Illinois and virtually. IMUNON recently announced alignment...

Continue reading

Dragonfly Energy Partners with the National Forest Foundation to Plant Thousands of Trees for Earth Day

Dragonfly Energy’s collaboration with the National Forest Foundation underscores the company’s continued commitment to sustainability and environmental stewardship. The pledge from Dragonfly Energy to plant thousands of trees is part of a bigger environmental plan initiated by the US Forest Service to combat climate change. Dragonfly Energy is committed to helping the National Forest Foundation reach its goal to successfully plant 50 million trees by the end of 2025.RENO, Nev., April 21, 2025 (GLOBE NEWSWIRE) — Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an industry leader in green energy storage and maker of Battle Born Batteries®, in recognition of Earth Day, is pledging to plant thousands of trees through a collaboration with the National Forest Foundation (NFF), the official non-profit...

Continue reading

BULGOLD Announces Filing of Fourth Quarter Financial Results for Three and Twelve Months Ended December 31, 2024

TORONTO, April 21, 2025 (GLOBE NEWSWIRE) — BULGOLD Inc. (TSXV: ZLTO) (the “Company” or “BULGOLD”) is pleased to announce that it has filed its audited annual financial statements and MD&A for the year ended December 31, 2024. For the year ending December 31, 2024, the company incurred a net comprehensive loss of $642,831 ($0.02 per share). On December 31, 2024, the company had cash (and cash equivalents) of $345,204. About BULGOLD Inc. BULGOLD is a gold exploration company focused on the exploration and development of mineral exploration projects in Central and Eastern Europe. The Company controls 100% of three quality quartz-adularia epithermal gold projects located in the Bulgarian and Slovak portions of the Western Tethyan Belt: the Lutila Gold Project, the Kostilkovo Gold Project and the Kutel Gold Project. Management...

Continue reading

Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East

NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer’s disease, Parkinson’s disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today announced that Marwan Noel Sabbagh, MD, Professor of Neurology at Barrow Neurological Institute and Chairman of Anavex’s Scientific Advisory Board gave an oral presentation titled, “Oral Blarcamesine Novel Mechanism for Alzheimer Disease: Autophagy Restoration through Upstream SIGMAR1 Activation Clinical Efficacy Phase IIb/III Trial” at the 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle...

Continue reading

Nano Dimension Provides Update on Desktop Metal

Waltham, Massachusetts, April 21, 2025 (GLOBE NEWSWIRE) — Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension” or the “Company”), a leader in Digital Manufacturing solutions, today provided an update on Desktop Metal. Desktop Metal, a subsidiary of Nano Dimension, has commenced a process to explore all available strategic alternatives to address its liabilities and liquidity needs. Desktop Metal has appointed Robert Warshauer to its Board of Directors and engaged Piper Sandler & Co. and FTI Consulting, Inc. as financial advisers. No assurances can be given as to the outcome or timing of the strategic review process. Nano Dimension plans to share additional details during its upcoming 2024 financial results and 2025 outlook call, expected to be held in late April 2025. About Nano Dimension Driven by strong trends in onshoring,...

Continue reading

American Tungsten Corp. to Participate at Top Shelf Partners Commodities Global Expo 2025

Vancouver, BC, April 21, 2025 (GLOBE NEWSWIRE) — American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) is pleased to announce its attendance and participation at Top Shelf Partners Commodities Global Expo 2025. The event will take place on May 11th – 13th, 2025, at the Four Seasons in Fort Lauderdale, Florida, U.S., and will focus on connecting key institutional investors with companies supporting critical minerals supply chain resilience and global security, particularly from a U.S. perspective.American Tungsten’s participation in the event underscores the Company’s commitment to advancing dialogue around the importance of securing domestic production capabilities for critical minerals in the United States and its continued long-term strategic plans to advance its flagship tungsten...

Continue reading

Zevra Files Definitive Proxy Statement and Mails Letter to Stockholders

Highlights 54.8% Total Stockholder Return Under Refreshed Board and Management Team Zevra Continues Growth Trajectory into a Global Commercial Rare Disease Company with Consistent Execution, New Product Launches, and Significant Financial Flexibility to Execute Strategic Plan Urges Stockholders to Defend Board Independence from Majority Influence by Individual 2.8% Stockholder, Mangless, Who Had Three Nominees Elected to the Board in 2023 Mangless Has Not Detailed any Strategies, Plans, or New Ideas to Improve Zevra’s Business and Appears Solely Focused on Replacing Two Highly Qualified Directors Board and Management Urge Stockholders to Vote “FOR” Zevra’s Highly-Qualified and Experienced Director Nominees on the WHITE Proxy Card CELEBRATION, Fla., April 21, 2025 (GLOBE NEWSWIRE) —  Zevra Therapeutics, Inc. (NasdaqGS:...

Continue reading

PX Energy, an Expanding Vertically Integrated Refinery and Mining Operation Located in Southern Brazil, Intends to Go Public Through a Business Combination with Papaya Growth Opportunity Corp. I, Including a Committed $10 Million Investment

TORONTO, April 21, 2025 (GLOBE NEWSWIRE) — PX Energy (“PX” or the “Company”), a vertically-integrated refined products manufacturer serving the Brazilian market for refined oil and agricultural grade products (through its parent company, Forbes & Manhattan Resources Inc.), and Papaya Growth Opportunity Corp. I (“PPYA”) announced today that they have entered into a definitive business combination agreement (the “BCA” and the transactions contemplated under the BCA, the “Business Combination” or the “Transaction”). Upon the completion of the Business Combination, the combined company will retain its name “PX Energy” and its headquarters in Brazil, and its ordinary shares to be listed on Nasdaq. PX Energy website is located at: https://pxenergy.com.brPhotograph of the PXenergy refinery facilities located in Parana State, BrazilPX...

Continue reading

BioStem Technologies to Present at the Centri Capital Conference

The presentation will be webcast at 10:30 AM ET on April 22, 2025 POMPANO BEACH, Fla., April 21, 2025 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, is pleased to announce that its Chief Executive Officer, Jason Matuszewski, will be presenting and holding one-on-one meetings at the upcoming Centri Capital Conference on April 22, 2025, taking place at the Nasdaq headquarters in New York City. BioStem Technologies Presentation Access:Presenter: Jason Matuszewski, Chief Executive Officer Date: Tuesday, April 22, 2025 Time: 10:30 AM ET Webcast Link & Archive: HERE 1-on-1 Meeting Request: adam@holdsworthco.comJoin BioStem’s Distribution List & Social Media:To follow...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.